Search

Olympic gymnast Shannon Miller was diagnosed with germ cell ovarian cancer, a very rare disease, in 2011 and treated at Memorial Sloan Kettering. Learn more about her inspiring story.

… Thursday, July 3, 2014 Summary Olympic gymnast Shannon Miller was diagnosed with germ cell ovarian cancer, a very rare disease, in 2011 and treated at Memorial Sloan Kettering. Learn more about her inspiring story. “Celebrating survivorship is an important reminder of why MSK exists.” —Memorial Sloan

Multiple copies of a gene called YES1 appear to be responsible for certain precision drugs losing their effectiveness.

… Thursday, June 7, 2018 Summary A collaborative study between scientists at Memorial Sloan Kettering and the New York Genome Center has identified one way that lung cancer cells outsmart a common targeted drug therapy. The results, reported in the Proceedings of the National Academy of Sciences, pave

Radiologist and molecular imaging researcher Moritz Kircher was awarded a Brain and Immuno-Imaging Grant by The Dana Foundation. This three-year grant supports the development of a dual-modality MRI-Raman nanoparticle that allows combined pre-and intra-operative visualization of glioblastomas.

… Wednesday, November 30, 2011 Radiologist and molecular imaging researcher Moritz Kircher  was awarded a Brain and Immuno-Imaging Grant by The Dana Foundation. This three-year grant supports the development of a dual-modality MRI-Raman nanoparticle that allows combined pre-and intra-operative visualization

Diagnosed with ovarian cancer at 51, Pauline Larkin feared her racing days were over — within the year, she was running in the NYC marathon with her MSK doctors by her side.

… Thursday, April 10, 2025 When 51-year-old Pauline Larkin was diagnosed with ovarian cancer in January 2024, she wasn’t sure she would ever lace up her running shoes again. It all started a few days after finishing the 2023 TCS New York City Marathon , when she felt cramps and bloating. Maybe she went

Two encouraging Memorial Sloan Kettering Cancer Center (MSK) studies were featured in this year’s American Association for Cancer Research (AACR) Annual Meeting press program.

… Tuesday, April 21, 2015 Two encouraging Memorial Sloan Kettering Cancer Center (MSK) studies were featured in this year’s American Association for Cancer Research (AACR) Annual Meeting press program. The AACR is the world’s oldest and largest professional organization dedicated to advancing cancer research

Memorial Sloan Kettering researchers have developed a powerful new way to study human disease using stem cells whose genomes can be manipulated at will.

… Thursday, August 7, 2014 Summary Memorial Sloan Kettering researchers have developed a powerful new way to study human disease using stem cells whose genomes can be manipulated at will. Memorial Sloan Kettering researchers have pioneered a new method to study complex genetic conditions including cancers

Our findings indicate that surgical site infections can be reduced effectively over the long term with a hospital-wide implementation of multidisciplinary best practices.

… Thursday, December 13, 2018 Implementation of a multidisciplinary care bundle composed of 13 perioperative components has significantly decreased the rate of surgical site infections (SSIs) among patients undergoing colorectal cancer surgery at Memorial Sloan Kettering Cancer Center, according to our

The Specialized Programs of Research Excellence (SPORE) grant will fund efforts focusing on the development of new treatments.

… Tuesday, September 7, 2021 Memorial Sloan Kettering Cancer Center has received a major grant from the US National Institutes of Health (NIH) to conduct research related to leukemia . It is the sixth grant of this type to be received by MSK investigators. It is referred to as a SPORE grant, for Specialized

Pediatric surgeon J. Ted Gerstle, MD, FACS, FRCS, has been named the new Chief of the Pediatric Surgery Service in the Department of Surgery at Memorial Sloan Kettering Cancer Center (MSK).

… Thursday, July 12, 2018 Pediatric surgeon J. Ted Gerstle, MD, FACS, FRCS , has been named the new Chief of the Pediatric Surgery Service in the Department of Surgery at Memorial Sloan Kettering Cancer Center (MSK). An accomplished physician and leader, Dr. Gerstle most recently served as Director of

The immunotherapy drug nivolumab is now approved for patients whose Hodgkin lymphoma has failed other treatments.

… Thursday, May 19, 2016 https://www.youtube.com/watch?v=lrB1gjztQSk The immunotherapy drug nivolumab is giving hope to Hodgkin lymphoma patients like Ariella after standard treatments don’t work. Video courtesy Cancer Research Institute. Summary Patients with Hodgkin lymphoma whose disease returns after